INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS
- 作者: Lysenko A.S1, Seliverstov E.S1, Zubareva E.V1
-
隶属关系:
- Belgorod State National Research University
- 期: 卷 15, 编号 3S (2020)
- 页面: 99-99
- 栏目: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/122852
- DOI: https://doi.org/10.23868/gc122852
- ID: 122852
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
全文:
作者简介
A. Lysenko
Belgorod State National Research University
Email: anngeneva@yandex.ru
Belgorod, Russia
E. Seliverstov
Belgorod State National Research UniversityBelgorod, Russia
E. Zubareva
Belgorod State National Research UniversityBelgorod, Russia
参考
- McCubrey J., Steelman L., Bertrand F. et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014; 5(10): 2881-911.
- Domoto T., Pyko I., Furuta T. et al. Glycogen synthase kinase-3p is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 2016; 107(10): 1363-72.
补充文件
